The STRC gene turned out to be a significant contributor to AR NSHL also in this cohort, as previous works already reported [4]; in particular, the incidence of STRC deletions has been estimated at between 1% and 5% in HL patients [36]. The gene discussed is STRC; the disease is Hodgkins lymphoma.